Diffusion weighted imaging in early prediction of neoadjuvant chemotherapy response in breast cancer
Conclusion ADC value can predict responder from non-responder as early as after the first cycle of chemotherapy.
Source: The Egyptian Journal of Radiology and Nuclear Medicine - Category: Nuclear Medicine Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Nuclear Medicine | Radiology | Study